Standards & Regulation

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.

How is the Indian pharmaceutical industry adapting to meet new demands?

Drug development needs to move more rapidly, but not at the expense of safety.

We’re making progress on standardizing single-use systems – and it could mean a more cost-effective supply chain.

How are counterfeiters exploiting the COVID-19 pandemic to make a profit?

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

How Raman spectroscopy-based technologies enable the pharma industry to streamline analytical workflows.

How can end-to-end supply chain management systems be used to prevent the movement and sale of fake and falsified medicines?

Adding authentication technologies to tablets could further help protect patients against fake drugs.

A position paper outlines why manufacturers must improve data integrity for excipients.